End-of-day quote
Shanghai S.E.
06:00:00 2024-05-19 pm EDT
|
5-day change
|
1st Jan Change
|
49
CNY
|
-0.99%
|
|
+7.36%
|
-7.46%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,907
|
4,026
|
9,532
|
6,069
|
9,835
|
9,102
|
-
|
-
|
Enterprise Value (EV)
1 |
3,907
|
4,026
|
9,532
|
6,069
|
9,835
|
9,102
|
9,102
|
9,102
|
P/E ratio
|
52.3
x
|
36.3
x
|
55.2
x
|
32.2
x
|
56.3
x
|
41.5
x
|
31.4
x
|
26.4
x
|
Yield
|
1.1%
|
1.07%
|
0.55%
|
-
|
0.94%
|
0.67%
|
0.92%
|
0.96%
|
Capitalization / Revenue
|
12.4
x
|
9.96
x
|
15.3
x
|
9.17
x
|
13.8
x
|
10.4
x
|
8.33
x
|
7.12
x
|
EV / Revenue
|
12.4
x
|
9.96
x
|
15.3
x
|
9.17
x
|
13.8
x
|
10.4
x
|
8.33
x
|
7.12
x
|
EV / EBITDA
|
-
|
28.7
x
|
43.3
x
|
-
|
40.1
x
|
27.8
x
|
22.8
x
|
18.2
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
4.36
x
|
4.18
x
|
8.72
x
|
4.93
x
|
7.3
x
|
6.11
x
|
5.14
x
|
4.63
x
|
Nbr of stocks (in thousands)
|
185,746
|
185,746
|
185,746
|
185,746
|
185,746
|
185,746
|
-
|
-
|
Reference price
2 |
21.04
|
21.68
|
51.32
|
32.67
|
52.95
|
49.00
|
49.00
|
49.00
|
Announcement Date
|
2/27/20
|
2/23/21
|
2/27/22
|
2/27/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
315.3
|
404.2
|
624.7
|
662
|
711.7
|
875.3
|
1,092
|
1,278
|
EBITDA
1 |
-
|
140.2
|
220.2
|
-
|
245
|
327
|
400
|
501
|
EBIT
1 |
85.13
|
123.9
|
197.2
|
190.2
|
195.4
|
248.8
|
318.4
|
384
|
Operating Margin
|
27%
|
30.65%
|
31.57%
|
28.73%
|
27.45%
|
28.42%
|
29.15%
|
30.04%
|
Earnings before Tax (EBT)
1 |
86.83
|
128.4
|
197.4
|
193.2
|
197.4
|
251.5
|
321
|
387
|
Net income
1 |
74.69
|
110.9
|
172.9
|
188.2
|
174
|
219
|
289.4
|
344.3
|
Net margin
|
23.69%
|
27.44%
|
27.67%
|
28.44%
|
24.45%
|
25.02%
|
26.49%
|
26.94%
|
EPS
2 |
0.4022
|
0.5971
|
0.9303
|
1.013
|
0.9400
|
1.180
|
1.560
|
1.853
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.2314
|
0.2314
|
0.2814
|
-
|
0.5000
|
0.3300
|
0.4500
|
0.4700
|
Announcement Date
|
2/27/20
|
2/23/21
|
2/27/22
|
2/27/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
19.2%
|
12%
|
16.9%
|
16.3%
|
13.6%
|
14.8%
|
16.5%
|
17.5%
|
ROA (Net income/ Total Assets)
|
-
|
10.5%
|
14.4%
|
-
|
13.5%
|
11.8%
|
13.1%
|
13.9%
|
Assets
1 |
-
|
1,058
|
1,199
|
-
|
1,289
|
1,850
|
2,216
|
2,474
|
Book Value Per Share
2 |
4.820
|
5.190
|
5.890
|
6.620
|
7.250
|
8.020
|
9.540
|
10.60
|
Cash Flow per Share
2 |
0.4300
|
0.4800
|
0.8300
|
1.300
|
1.330
|
1.000
|
1.440
|
1.760
|
Capex
1 |
60.3
|
124
|
208
|
155
|
52.9
|
124
|
139
|
115
|
Capex / Sales
|
19.14%
|
30.7%
|
33.27%
|
23.39%
|
7.44%
|
14.17%
|
12.68%
|
9%
|
Announcement Date
|
2/27/20
|
2/23/21
|
2/27/22
|
2/27/23
|
2/22/24
|
-
|
-
|
-
|
Average target price
53
CNY Spread / Average Target +8.16% Consensus |
1st Jan change
|
Capi.
|
---|
| -7.46% | 1.27B | | +5.31% | 106B | | -6.47% | 63.94B | | +72.86% | 49.34B | | +16.94% | 39.15B | | +5.28% | 32.86B | | +14.48% | 20.29B | | +15.10% | 17.21B | | +18.07% | 15.28B | | +4.83% | 14.58B |
Other Commodity Chemicals
|